Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Psoriasis increases annual healthcare costs by $4,044 per patient, with biologic treatments costing significantly more than phototherapy.

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

Costovertebral arthritis can cause chronic back pain in SLE patients and needs thorough evaluation.

Pix Liquida helped a man recover from patchy hair loss.

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.

PRP shows promise for spinal pain but needs more guidelines before widespread use.

Pharmacists play a crucial role in patient care and optimizing treatment outcomes.

Naproxen is not the cause of hair loss in a child; it's due to a toxic event with expected hair regrowth.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Repurposed drugs offer a promising, safe, and effective acne treatment.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Copaiba resin oil shows promise for cancer therapy and is safe for topical use.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Australian dermatologists are updating their prescriptions for male pattern baldness.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Finasteride helps reduce pain and inflammation in animals.